|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
4/2005
vol. 107 abstract:
Case report
Botulinum toxin injection to the lateral rectus for the treatment of intractable diplopia
Anna Broniarczyk-Loba
1
,
Iwona Laudańska-Olszewska
1
,
Olimpia Nowakowska
1
Klinika Oczna 2005, 107 (4): 690-693
Online publish date: 2005/12/18
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
The aim of the study is to evaluate the use of botuline A (BTXA) as a form of treatment for squinting patients with onerous diplopia. Two patients with exotropia and one patient with esotropia had injections of BTX A to the lateral rectus muscles of the affected side. The number of injections ranged from 1 to 2. Two patients went on to have surgery. All patients in our study found that BTX A improved their symptoms of diplopia. We conclude that BTX A has an important role in the treatment of squinting patients with burdensome diplopia.
keywords:
Botuline, squint, diplopia |
|
POLSKI
